Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2002
10/10/2002WO2002079224A2 Isolated human nadph oxidase, nucleic acid molecules encoding said proteins, and uses thereof
10/10/2002WO2002079217A1 A hepatitis b virus surface antigen mutant and methods of detection thereof
10/10/2002WO2002079150A2 Glycorandomization and the production of novel erythronolide and coumarin analogs
10/10/2002WO2002078847A1 Instrument and method for recovering nucleic acid
10/10/2002WO2002078846A1 Instrument and method for collecting nucleic acids
10/10/2002WO2002078835A2 Substrates, preparation and use
10/10/2002WO2002078766A2 Combination therapy
10/10/2002WO2002078734A1 Production of peptides in plants as n-terminal viral coat protein fusions
10/10/2002WO2002078733A1 Monocyte-specific particulate delivery vehicle
10/10/2002WO2002078732A1 A noval vaccine formulation consisting of dna vaccine inactivated virus
10/10/2002WO2002078731A1 Module of pd-1 interactions with its ligands
10/10/2002WO2002078730A2 Use of neublastin polypeptides for treating neuropathic pain
10/10/2002WO2002078715A1 Method for induction of an antigen specific anti-inflammatory response
10/10/2002WO2002078640A2 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
10/10/2002WO2002078631A2 Improved conditionally replicating vectors for inhibiting viral infections
10/10/2002WO2002078621A2 Replication-competent recombinant virus and methods of use thereof
10/10/2002WO2002078614A2 Lps-responsive chs1/beige-like anchor gene and therapeutic applications thereof
10/10/2002WO2002078613A2 Immunoglobulin construct containing anti-mucin variable domain sequences for eliciting an anti-idiotype anti-tumor response
10/10/2002WO2002078612A2 Thrombopoietin (tpo) synthebody for stimulation of platelet production
10/10/2002WO2002078608A2 A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent
10/10/2002WO2002078607A2 Mucin peptide with immunoenhancing properties
10/10/2002WO2002078603A2 Plasmodium falciparum erythrocyte binding protein baebl for use as a vaccine
10/10/2002WO2002078598A2 Peptides and antibodies to muc 1 proteins
10/10/2002WO2002078526A2 Cancer-testis antigens
10/10/2002WO2002078438A2 Tissue-preferred promoter from maize
10/10/2002WO2002078437A2 Novel pesticidal toxins
10/10/2002WO2002078435A1 Transgenic mice containing gnb1 gene disruptions
10/10/2002WO2002078429A1 Plastid transformation of lycopersicon plants
10/10/2002WO2002078427A2 Specification of meiocyte and tapetal cell layers in plants
10/10/2002WO2002078426A2 Final segregation of male meiotic products in plants
10/10/2002WO2002078420A2 Molecules for disease detection and treatment
10/10/2002WO2002070552A8 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF
10/10/2002WO2002065093A3 Methods and compositions of amplifying rna
10/10/2002WO2002063018A3 Method for the production of plant seed with modified fibre content and modified seed coat
10/10/2002WO2002062131A3 Method of cloning transgenic mammalian animals using pseudonuclei
10/10/2002WO2002060386A3 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK)
10/10/2002WO2002059149A3 Pro-apoptotic proteins and dna molecules encoding them
10/10/2002WO2002057305A9 A gene whose expression promotes differentiation of myeloid progenitor cells into neutrophils and/or monocytes/macrophages
10/10/2002WO2002053734A3 Methods and compositions for inhibiting neoplastic cell growth
10/10/2002WO2002047610A3 Marine actinomycete taxon for drug and fermentation product dicovery
10/10/2002WO2002046373A8 Method of collecting placental stem cells
10/10/2002WO2002044323A3 Vectors for expressing heterologous peptides at the amino-terminus of potyvirus coat protein, methods for use thereof, plants infected with same and methods of vaccination using same
10/10/2002WO2002036753A3 Human triacylglycerol lipase
10/10/2002WO2002035237A3 Method for in vivo identification of intracellular epitopes
10/10/2002WO2002034895A3 Novel aggrecanase molecules
10/10/2002WO2002034763A3 Mucin comprising vehicle for the transport of biologically-active agents
10/10/2002WO2002033045A3 Oligonucleotide - facilitated coalescence
10/10/2002WO2002029069A3 A nitrate-responsive plant root specific transcriptional factor
10/10/2002WO2002029045A3 Method for the production of vitamin k-dependent proteins
10/10/2002WO2002029025A3 Factor vii glycoforms
10/10/2002WO2002026820A3 Immunomodulatory protein derived from the yaba monkey tumor virus
10/10/2002WO2002024868A3 Non-human model of gestational and adult folate deficiency and uses thereof
10/10/2002WO2002016419A3 Progression suppressed gene 13 (psgen 13) and uses thereof
10/10/2002WO2002014495B1 Enhanced homologous recombination mediated by lambda recombination proteins
10/10/2002WO2002012481A3 Enhancement of industrial production by increasing substrate transport
10/10/2002WO2002010766A3 Assay method, peptides and reagent kits for testing mrp-specific inhibitors
10/10/2002WO2002006834A3 Nested sorting and high throughput screening
10/10/2002WO2002006321A3 Polycomb gene zmfie2 from maize
10/10/2002WO2002004956A9 Method of identifying conformation-sensitive binding peptides and uses thereof
10/10/2002WO2002004612A3 Drug metabolizing enzymes
10/10/2002WO2002004007A9 Stable (fixed) forms of viral capsid proteins, fusion proteins and uses thereof
10/10/2002WO2002002599A3 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR17, AND USES THEROF
10/10/2002WO2002000714A3 Receptor for phosphoinositides-1 associated scaffold protein
10/10/2002WO2002000694A3 Modified morbillivirus v proteins
10/10/2002WO2001098353A3 Secreted proteins
10/10/2002WO2001097868A9 The inactivation of nucleic acids using broad-spectrum pulsed light
10/10/2002WO2001090346A3 Gene recombination and hybrid protein development
10/10/2002WO2001090340A3 Assembly of large viral genomes and chromosomes from subclones
10/10/2002WO2001085982A3 Mixed cell systems for the detection of viruses
10/10/2002WO2001081606A3 Polynucleotide sequences from rice
10/10/2002WO2001079550A3 Genetic testing for determining the risk of pouchitis development
10/10/2002WO2001077174A3 Human transporters and ion channels
10/10/2002WO2001076529A9 Fertility associated antigen and methods of use thereof
10/10/2002WO2001073017A3 Regulation of human adp-ribosylation factor-related protein
10/10/2002WO2001071039A3 Combined polynucleotide sequences as discrete assay endpoints
10/10/2002WO2001066798A3 Random truncation and amplification of nucleic acid
10/10/2002WO2001066755A3 Monocotyledonous plant genes and uses thereof
10/10/2002WO2001064869A3 Tumor-related antigen
10/10/2002WO2001059082A9 27802, an adenylate kinase
10/10/2002WO2001053324A8 Novel haptotactic peptides
10/10/2002WO2000000601A3 Production of low-temperature, salt-and drought-tolerant transgenic cereal plants
10/10/2002US20020148008 Nucleotide sequences coding protein for use in controlling latency in plants
10/10/2002US20020148007 Seed-preferred promoter from barley
10/10/2002US20020148006 Transgenic plants with modified sterol compositions
10/10/2002US20020148005 Method of using DNA episomes to suppress gene expression in plants
10/10/2002US20020148004 Modification of a plant disease resistance gene specificity and method for engineering altered specificity
10/10/2002US20020148003 Expression vector coding enzymes associated in amino acid biosynthesis for use in the generation of human and animal nutrients
10/10/2002US20020148002 Plasmids and methods for construction of non-redundant, saturation, gene-disruption plant libraries
10/10/2002US20020148001 Expression vector for use in the generation of animal models for analysis of genetic disorders
10/10/2002US20020148000 HS-40 enhancer-containing vector in transgenic animals
10/10/2002US20020147999 Reducing neuronal tangles in alzhemier's patients; obtain human, administer modulator, monitor development of neuronal tangles in, reduction in neuronal tangles indicates modulator
10/10/2002US20020147371 Forming lycopene; genetic engineering; culture product
10/10/2002US20020147332 Novel nucleoside and oligonucleotide analogues
10/10/2002US20020147330 Probe carrier for use in the diagnosis and analysis of genetic disorders
10/10/2002US20020147329 Method of modulating tissue growth using Frzb protein
10/10/2002US20020147328 Connective tissue growth factor homologs
10/10/2002US20020147327 Glucocorticoid receptor protein for use in the treatment of arthritis and asthma
10/10/2002US20020147326 Fusion protein for use in the treatment of autoimmune diseases tissue grafting defect
10/10/2002US20020147325 Antibodies to receptor protein kinases
10/10/2002US20020147324 RPS gene family, primers, probes, and detection methods